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The CIAO Study is a multicenter observational study currently underway in 66 European medical institutions over
the course of a six-month study period (January-June 2012).
This preliminary report overviews the findings of the first half of the study, which includes all data from the first
three months of the six-month study period.
Patients with either community-acquired or healthcare-associated complicated intra-abdominal infections (IAIs) were
included in the study.
912 patients with a mean age of 54.4 years (range 4–98) were enrolled in the study during the first three-month
period. 47.7% of the patients were women and 52.3% were men. Among these patients, 83.3% were affected by
community-acquired IAIs while the remaining 16.7% presented with healthcare-associated infections. Intraperitoneal
specimens were collected from 64.2% of the enrolled patients, and from these samples, 825 microorganisms were
collectively identified.
The overall mortality rate was 6.4% (58/912). According to univariate statistical analysis of the data, critical
clinical condition of the patient upon hospital admission (defined by severe sepsis and septic shock) as well
as healthcare-associated infections, non-appendicular origin, generalized peritonitis, and serious comorbidities
such as malignancy and severe cardiovascular disease were all significant risk factors for patient mortality.
White Blood Cell counts (WBCs) greater than 12,000 or less than 4,000 and core body temperatures exceeding
38°C or less than 36°C by the third post-operative day were statistically significant indicators of patient
mortality.* Correspondence: m.sartelli@virgilio.it
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Intra-abdominal infections (IAIs) include a wide spectrum
of pathological conditions, ranging from uncomplicated
appendicitis to fecal peritonitis.
From a clinical perspective, IAIs are classified in two
major categories: complicated and uncomplicated [1].
In the event of a complicated IAI, the infectious process
proceeds beyond a singularly affected organ and causes ei-
ther localized peritonitis (intra-abdominal abscesses) or
diffuse peritonitis. Effectively treating patients with com-
plicated intra-abdominal infections involves both source
control and antibiotic therapy.
Source control is a broad term encompassing all mea-
sures undertaken to eliminate the source of infection
and control ongoing contamination [2].
The most common source of infection in community-
acquired intra-abdominal infections is the appendix, fol-
lowed by the colon, and then the stomach. Dehiscence
complicates 5–10% of intra-abdominal bowel anastomoses
and is associated with an increased mortality rate [3].
Antimicrobial therapy plays an integral role in the
management of intra-abdominal infections; empiric anti-
biotic therapy should be initiated as early as possible.
Bacterial antibiotic resistance has become a very preva-
lent problem in treating intra-abdominal infections, yet
despite this elevated resistance, the pharmaceutical in-
dustry has surprisingly few new antimicrobial agents cur-
rently in development.
In the last decade, the increased emergence of multi-
drug-resistant (MDR) bacteria, such as extended-spectrum
beta-lactamase (ESBL)-producing Enterobacteriaceae, Car-
bapenem-resistant Klebsiella pneumoniae, Pseudomonas
aeruginosa, Acinetobacter baumannii, Vancomycin-resist-
ant Enterococcus, and Methicillin-resistant Staphylococcus
aureus, has foreshadowed a troubling trend and become
an issue of key concern in the medical community regard-
ing the treatment of intra-abdominal infections.
In the specific context of intra-abdominal infections,
ESBL-producing Enterobacteriaceae pose the greatest re-
sistance-related problem. Today these pathological
microorganisms are frequently found in both nosocomial
and community-acquired IAIs.
The recent and rapid spread of serine carbapenemases
in Klebsiella pneumoniae (KPC) has become an import-
ant issue concerning antimicrobial therapy in hospitals
worldwide and is of primary importance in properly opti-
mizing the use of carbapenems based on a patient’s indi-
cation and exposure criteria [4].
Study design
The purpose of the CIAO Study is to describe the epi-
demiological, clinical, microbiological, and treatment pro-
files of community-acquired and healthcare-associated
complicated intra-abdominal infections (IAIs) based onthe data collected over a six-month period (January 2012
to June 2012) from 66 medical institutions (see Figure 1)
across Europe. This preliminary report overviews the
findings of the first half of the study, which includes
all data from the first three months of the six-month
study period.
Patients with either community-acquired or healthcare-
associated complicated intra-abdominal infections (IAIs)
were included in the study.
In each treatment center, the center coordinator collects
and compiles the data in an online case report database.
The collected data include the following: (i) patient
and disease characteristics, i.e. demographic data, type
of infection (healthcare- or community-acquired),
severity criteria, previous curative antibiotic therapy
administered in the seven days preceding surgery; (ii)
origin of infection, surgical procedures performed, and
antibiotic therapies administered; and (iii) microbio-
logical data, i.e. identification of bacteria and microor-
ganismal pathogens within the peritoneal fluid, the
presence of yeasts (if applicable), and the antibiotic
susceptibilities of bacterial isolates.
This observational study does not attempt to change
or modify the laboratory or clinical practices of the par-
ticipating physicians or their respective institutions, and
neither informed consent nor formal approval by an
Ethics Committee is required.
The study will continue to meet and abide by the stan-
dards outlined in the Declaration of Helsinki and Good
Epidemiological Practices.
A Scientific Committee was established to impartially
assess the objectives, methodology, and overall scientific
quality of the project.
The study is monitored by the Coordination Center,
which investigates and verifies missing or unclear data
submited to the central database.
Statistical analyses were performed using MedCalcW
statistical software.
Results
Patients
912 patients with a mean age of 54.4 years (range 4–98)
were enrolled in the study during the first three-month
period. 432 patients (47.7%) were women and 480 (52.3%)
were men. Among these patients, 753 (83.3%) were
affected by community-acquired IAIs while the remaining
159 (16.7%) suffered from healthcare-associated infections.
Intraperitoneal specimens were collected from 586 (64.2%)
of the enrolled patients.
338 patients (37%) were affected by generalized peri-
tonitis while 574 (63%) suffered from localized peritonitis
or abscesses.
123 patients (13.5%) were admitted in critical condi-
tion (severe sepsis, septic shock).
Figure 1 Geographic distribution of the CIAO study.
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logical assessments recorded upon patient admission.Source control
The various sources of infection are outlined in Table 3.
The most frequent source of infection was acute appendi-
citis. 350 cases (38.4%) were attributable to this condition.Table 1 Clinical findings
Clinical findings Patients n° (%)
Abdominal pain 102 (11,2%)
Abdominal pain, abdominal rigidity 87 (9,5%)
Abdominal pain, abdominal rigidity,
T> 38°C or <36°C, WBC >12000 or< 4000
38 (4,2%)
Abdominal pain, abdominal rigidity,
T> 38°C or <36°C,
184 (20,2)
Abdominal pain, abdominal rigidity,
WBC >12000 or< 4000
182 (20%)
Abdominal pain, T> 38°C or <36°C, 28 (3%)
Abdominal pain, T> 38°C or <36°C,
WBC >12000 or< 4000
100 (11%)
Abdominal pain, WBC >12000 or< 4000 138 (15,1)
T> 38°C or <36°C 5 (0,5%)
T> 38°C or <36°C, WBC >12000 or< 4000 22 (2,4%)
WBC >12000 or< 4000 15 (1,7)
Not reported 11 (1,2%)108 cases (11.8%) were attributable to post-operative
infections. Anastomotic leaks were the most prevalent
cause of post-operative infection. Of the patients with
post-operative infections, 34.2% resulted from colo-rectal
leaks, 15.7% from upper gastro-intestinal leaks, 12% from
pancreatic leaks, 11.1% from biliary leaks, and 0.9% from
urinary leaks.
The most frequently performed procedure employed to
address complicated appendicitis was the open appendec-
tomy. 189 patients (54%) admitted for complicated appendi-
citis underwent open appendectomies: 135 patients (71.4%)Table 2 Radiological procedures
Radiological procedures Patients n° (%)
Abdomen X ray 91 (10%)
Abdomen X ray, CT 73 (8%)
Abdomen X ray, ultrasound 167 (18,3%)
Abdomen X ray, ultrasound, CT 88 (9,6%)
Abdomen X ray, ultrasound, MRI 2 (0,2%)
CT 208 (22,8%)
Ultrasound 153 (16,8%)
Ultrasound, CT 74 (8,1%)
Ultrasound, CT, MRI 1 (0,1%)
Ultrasound, MRI 2 (0,2%)
Not reported 53 (5,8%)
Table 3 Source of infection
Source of infection Patients n° (%)
Appendicitis 350 (38,4%)
Cholecystitis 131 (14,4%)
Post-operative 108 (11,8%)
Colonic non diverticular perforation 75 (8,2%)
Gastroduodenal perforations 74 (8,1%)
Diverticulitis 71 (7,8%)
Small bowel perforation 44 (4,8%)
Others 45 (4,9%)
PID 7 (0,8%)
Post traumatic perforation 7 (0,8%)
Table 4 Aerobic bacteria in the peritoneal fluids
Total 697 (100%)
Aerobic Gram negative bacteria 492 (70,6%)
Escherichia coli 314 (45%)
(Escherichia coli resistant to
third generation cephalosporins)
35 (5%)
Klebsiella pneuumoniae 55 (7,9%)
(Klebsiella pneumoniae resistant to third
generation cephalosporins)
19 (2,7%)
Enterobacter 28 (4%)
Proteus 14 (2%)
Pseudomonas 32 (4,6%)
Others 49 (7%)
Aerobic Gram positive bacteria 205 (29,7%)
Enterococcus faecalis 70 (10%)
Enterococcus faecium 31 (4,4%)
Staphylococcus Aureus 22 (3,1%)
Streptococcus spp. 48 (6,9%)
Others 34 (4,9%)
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for generalized peritonitis. A laparoscopic appendectomy
was performed on 143 patients (40.8%) presenting with
complicated acute appendicitis, 95 and 53 of whom under-
went the procedure for localized peritonitis/abscesses and
generalized peritonitis, respectively. Open colonic resection
was performed on three patients to address complicated ap-
pendicitis. In the other 15 cases of complicated appendicitis
(4.3%), conservative treatment (percutaneous drainage, sur-
gical drainage, and non-operative treatment) was per-
formed. 2.3% of patients underwent percutaneous drainage
and interval appendectomies to address appendicular
abscesses.
The most frequently performed procedure to address
cholecystitis was the open cholecystectomy. 66 cholecyst-
itis patients (50.4%) underwent this procedure. A laparo-
scopic cholecystectomy was performed on 46 patients
(35.1%). In the remaining cases, conservative treatment
methods (percutaneous drainage, non-operative treatment)
were alternatively employed.
The Hartmann resection was the most frequently per-
formed procedure to address complicated diverticulitis.
35 patients (49.3%) underwent a Hartmann resection,
and of these resections, the vast majority were open pro-
cedures (91% open compared to 9% laparoscopic). 23 of
these patients underwent a Hartmann resection for gen-
eralized peritonitis, while the remaining 12 underwent
the same procedure for localized peritonitis or abscesses.
Colo-rectal resection was performed in 16 cases (22.5%).
Contrastingly, laparoscopic resection was performed on
only two patients, (one patient with and one patient with-
out protective stoma). Open resection was performed on
14 patients (five with and nine without stoma protection).
The other patients received conservative treatment
(percutaneous drainage, non-operative treatment, surgi-
cal drainage and stoma). Seven patients (9.9%) under-
went laparoscopic drainage.
For patients with gastro-duodenal perforations, the
most frequent surgical procedure was gastro-duodenalsuture (63 patients). 57 patients underwent open gastro-
duodenal suture (85.1%) and six patients underwent
laparoscopic gastro-duodenal suture (8.1%). Two (2.7%)
patients underwent gastro-duodenal resection. The nine
remaining patients (12.2%) received conservative treat-
ment (non-operative treatment, surgical drainage).
Among the 44 patients with small bowel perforations, 35
underwent open small bowel resection (79.5%) and two
(4.5%) underwent laparoscopic small bowel resection. The
remaining seven patients were treated non-surgically.
Among the 75 patients with colonic non-diverticular
perforation, 25 patients (33.3%) underwent open Hartmann
resection, 27 (36%) underwent open resection with anasto-
mosis and without stoma protection, and 11 underwent
open resection with stoma protection (14.7%).
Source control was effective in 838 patients and in-
effective in 57 patients.Microbiology
Intraperitoneal specimens were collected from 586
(64.2%) patients.
Intraperitoneal specimens were isolated from 453 of the
753 patients with community-acquired intra-abdominal
infections (60.2%).
Among the remaining 159 patients with healthcare-
associated intra-abdominal infections, intraperitoneal
specimens were collected from 133 patients (83.6%).
The major pathogens involved in intra-abdominal
infections were found to be Enterobacteriaceae.
The aerobic bacteria identified in samples of peritoneal
fluid are reported in Table 4.
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lates comprised 8.1% (21/259) of all Escherichia coli isolates,
while Klebsiella pneumoniae ESBL isolates represented
19.3% (6/31) of all Klebsiella pneumoniae isolates.
ESBL-positive Enterobacteriaceae increased in the
group of patients with healthcare-associated infections.
Escherichia coli ESBL-positive isolates comprised 25.4%
(14/55) of all Escherichia coli isolates, while Klebsiella
pneumoniae ESBL isolates made up 54.2% (13/24) of
total Klebsiella pneumoniae isolates.
There were two isolates of Klebsiella pneumoniae that
proved to be resistant to Carbapenems. Both of these
Carbapenem-resistant Klebsiella pneumoniae isolates
were acquired in an in-hospital intensive care unit.
Among the identified aerobic gram-negative isolates,
there were 32 isolates of Pseudomonas aeruginosa (4.6%
among aerobic bacteria isolates).
There appeared to be few significant differences be-
tween the Pseudomonas isolates identified in healthcare-
associated and community-acquired infections.
The two Pseudomonas aeruginosa strains resistant to
carbapenems were also acquired in the intensive care unit.
Among the identified aerobic gram-positive bacteria,
Enterococci (E. faecalis and E. faecium) were identified in
101 cases (14.5% of all aerobic isolates). Eight glycopeptide-
resistant Enterococci were isolated (six were glycopeptide-
resistant Enterococcus faecalis isolates, and two were
glycopeptide-resistant Enterococcus faecium isolates).
Although Enterococci were also present in commu-
nity-acquired infections, they were far more prevalent in
healthcare-associated infections.
The identified peritoneal isolates from both healthcare-
associated and community-acquired IAIs are listed in
Table 5.
278 patients were tested for anaerobes.
83 different anaerobes were ultimately observed. The
most frequently identified anaerobic pathogen wasTable 5 Aerobic bacteria in community acquired and health-c
Community-acquired IAIs Isolates n° H
a
Aerobic bacteria 498 (100%) A
Escherichia coli 259 (52,2%) E
(Escherichia coli resistant to
third generation cephalosporins)
21 (4,2%) (E
t
c
Klebsiella pneumoniae 31 (6,2%) K
(Klebsiella pneumoniae resistant
to third generation cephalosporins)
6 (1,2%) (K
r
c
Pseudomonas 22 (4,4%) P
Enterococcus faecalis 37 (7,4%) E
Enterococcus faecium 17 (3,4%) EBacteroides. 57 Bacteroides isolates were observed during
the initial course of the study. Among the Bacteroides iso-
lates, there was one Metronidazole-resistant strain.
A complete overview of the identified anaerobic bac-
teria is reported in Table 6.
Additionally, there were 45 Candida isolates identified
among the 825 total isolates (4.7%). 36 were Candida
albicans and 9 were Candida non albicans. Two particular
candida isolates (one Candida albicans and one Candida
non albicans) appeared to be fluconazole-resistant (see
Table 7).
The prevalence of Candida was noticeably elevated in
the healthcare-associated IAI group (232 total isolates). 25
Candida isolates (10.8%) were observed in this group com-
pared to 20 Candida isolates (3.4%) in the community-
acquired IAI group (593 total isolates).
Outcome
The overall mortality rate was 6.4% (58/912).
232 patients (25.4%) were admitted to the intensive
care unit in the early recovery phase immediately follow-
ing surgery.
87 patients (9.5%) ultimately required a subsequent
“re-operation.” 72,4% of these re-laparotomies were “on-
demand” follow-up procedures that came about unex-
pectedly and 19,5% were planned re-operations. Overall,
8% of these patients underwent an “open abdomen”
procedure.
The median post-operative day for a subsequent re-
operation in the “open abdomen” group was 3.7 days
(range 2–5).
According to univariate statistical analysis (see Table 8),
a critical clinical condition (severe sepsis and septic
shock) upon hospital admission was the most significant
risk factor for death; indeed, the rate of patient mortality
was 31.7% (40/126) among critically ill patients (patients
presenting with septic shock and severe sepsis uponare associated IAIs
ealthcare
ssociated IAIs
Isolates n° P
erobic bacteria 199 (100%)
scherichia coli 55 (27,6%) 0,0002
scherichia coli resistant
o third generation
ephalosporins)
14 (7%) NS
lebsiella pneumoniae 24 (12%) 0,0275
lebsiella pneumoniae
esistant to third generation
ephalosporins)
13 (6,5%) 0,0005
seudomonas 10 (5%) NS
nterococcus faecalis 33 (16,6%) 0,002
nterococcus faecium 14 (7%) NS
Table 6 Anaerobic bacteria in the peritoneal fluids
Anaerobes 83
Bacteroides 57 (68,7%)
(Bacteroides resistant to metronidazole) 1 (1,2%)
Clostridium 6 (7,2%)
(Clostridium resistant to metronidazole) 1(1,2%)
Others 20 (24%)
Table 8 Risk factors for death during hospitalization
Risk Factors Mortality rate
in patients
with risk
factor
Mortality rate
in patients
without risk
factor
P
Critical ill condition at
the admission (Severe
sepsis, septic shock)
31,7% (40/126) 2,2% (18/786) <0,0001
Healthcare-associated
infection
12,9% (20/155) 5% (38/757) 0,0015
Non-appendicular origin (10,1%) 57/562 (0,3%) 1/350 <0,0001
Generalized peritonitis 12,4% (42/338) 2,8% (16/574) <0,0001
Delay in the initial
intervention (>24 hours)
11% (29/263) 4,5% (29/643) 0,0013
Comorbidity
Malignancy 13,8% (21/152) 4,9% (37/760) 0,0003
Serious cardiovascular
disease
17,4% (25/144) 3,6% (28/768) <0,0001
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786) for clinically stable patients (p< 0.0001).
For patients with healthcare-associated and commu-
nity-acquired infections, the mortality rates were 12.9%
(20/155) and 5% (38/757), respectively (p = 0.0015).
The mortality rate was 12.4% (42/338) for patients with
generalized peritonitis and only 2.8% (16/574) for patients
with localized peritonitis or abscesses (p< 0.001).
The mortality rate was 10.1% (57/562) for patients with
infections of non-appendicular origin and only 0,3% (1/
350) for patients with infections of appendicular origin
(p< 0.001).
Malignancy and serious cardiovascular disease were
the most significant comorbidities associated with an ele-
vated mortality rate. For those patients affected by malig-
nancy, the mortality rate was 13.8% (21/152), marking a
substantial increase from the 4.9% mortality rate (37/
760) for patients who did not suffer from malignancy
(p = 0.0003).
Similarly, the mortality rates for patients with and
without serious cardiovascular disease were 17.4% (25/
144) and 3.6%, respectively (28/768) (p< 0.0001).
Mortality rates did not vary to a statistically significant
degree between patients who received adequate source
control and those who did not. However, for patients
with a delayed initial intervention (a delay exceeding 24
hours) mortality was 11% (29/263), while, for patients
with prompt initial intervention, the mortality rate was
only 4.5% (29/643) (p = 0.0013).
Patients presenting with a WBC count greater than
12,000 or less than 4,000 and core body temperatures
greater than 38°C or less than 36°C by the third post-
operative day demonstrated an increased likelihood of
patient mortality (see Table 9).
For operated patients with a WBC count greater than
12,000 or less than 4,000 by post-operative day 3, theTable 7 Candida isolates in the peritoneal fluids
Candida 45
Candida albicans 36 (80%)
(Candida albicans resistant to fluconazole) 1 (2,2%)
Non albicans Candida 9 (20%)
(non albicans Candida resistant to fluconazole) 1 (2,2%)mortality rate was elevated to 24% (39/163), while this rate
remained at 2.6% (19/720) for patients with a normal
WBC count by the third post-operative day (p< 0.0001).
In patients with core body temperatures exceeding 38°C or
less than 36°C by the third post-operative day, the mortal-
ity rate was elevated to 12.3% (19/155) while it remained
at 5.3% (39/728) for patients exhibiting normal core body
temperatures (p= 0.0066).Discussion
Complicated intra-abdominal infections are an important
cause of morbidity and are frequently associated with
poor clinical prognoses, particularly for patients in high-
risk categories.
Source control encompasses all measures undertaken
to eliminate the source of infection and control ongoing
contamination.
In recent years, the medical community has debated
the proper surgical management of complicated intra-
abdominal infections.
Acute appendicitis is the most common intra-abdominal
condition requiring emergency surgery. However, this pre-
liminary report has demonstrated that complicated appen-
dicitis is also a frequent source of intra-abdominalTable 9 Predictive factors for death during
hospitalization
Predictive factors Mortality rate
in patients
with predictive
factors
Mortality rate
in patients
without predictive
factors
P
WBC> 12000 or< 4000
(post-operative day 3)
24% (39/163), 2,6% (19/720) <0,0001
T> 38°C or< 36°C
(post-operative day 3)
12,3% (19/155) 5,3% (39/728) 0,0066
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effective means of surgical treatment for addressing com-
plicated intra-abdominal infections, but open surgery still
retains many clinical advantages, including a reduced
probability of post-operative intra-abdominal abscesses
[5].
In patients with periappendiceal abscesses, the proper
course of surgical treatment remains a point of contention
in the medical community; however, this contention not-
withstanding, the most commonly employed treatment
appears to be drainage with subsequent appendectomy [6].
CIAO Study data indicate that the open approach was
used in 54% of complicated appendicitis cases while the lap-
aroscopic approach was favored and performed on 40.8% of
complicated appendicitis patients. Eight patients underwent
percutaneous drainage and interval appendectomies.
The laparoscopic versus open cholecystectomy debate
has been extensively investigated in recent years. In the
CIAO Study, the open cholecystectomy was the most fre-
quently performed procedure for addressing cholecystitis.
50.4% and 31.5% of cholecystitis patients underwent the
open and laparoscopic procedures, respectively.
The optimal surgical management of colonic diverticu-
lar disease complicated by peritonitis remains a contro-
versial issue in the medical community.
Hartmann’s resection has historically been considered
the procedure of choice for patients with generalized
peritonitis and continues to be a safe and reliable tech-
nique for performing an emergency colectomy in the
event of perforated diverticulitis, particularly in elderly
patients with multiple co-morbidities [7-9].
More recently, some reports have suggested that pri-
mary resection and anastomosis is the preferred approach
to addressing diverticulitis, even in the presence of diffuse
peritonitis [10-13].
According to the preliminary CIAO Study data, the
Hartmann resection was the most frequently employed
procedure for treating complicated diverticulitis. 49.3% of
patients underwent this surgical resection. Among the 35
enrolled patients who had undergone a Hartmann resec-
tion, 23 patients presented with generalized peritonitis and
12 presented with localized peritonitis or abscesses. 22.5%
of patients underwent colo-rectal resection to address
complicated diverticulitis.
The significance of microbiological workups of infected
peritoneal fluid taken from community-acquired intra-
abdominal infections has been debated in recent years.
Since the causative pathogens are often accurately pre-
dicted in low-risk patients with community-acquired IAIs,
some researchers believe bacteriological diagnosis to be su-
perfluous for these patients. The lack of clinical relevance
of many bacteriological cultures has been readily docu-
mented, especially in appendicitis cases in which the etio-
logical agents causing the peritonitis are easily predicted[14]. Other researchers assert that bacteriological diagnosis
is still important for low-risk patients with community-
acquired IAIs primarily because it may be of value in
detecting epidemiological changes in the resistance pat-
terns of pathogens associated with these infections and in
better assessing follow-up antibiotic therapy. In higher risk
patients with community-acquired IAIs and healthcare-
associated IAIs, cultures from the site of infection should
always be always obtained.
According to the preliminary CIAO Study data, intraperi-
toneal specimens were collected from the 64.2% of enrolled
patients; these samples were obtained from 60.2% of
patients with community-acquired intra-abdominal infec-
tions and 83.9% of patients with healthcare-associated intra-
abdominal infections.
Routine susceptibility testing for anaerobic organisms
continues to prove difficult for many laboratories given a
variety of economic and logistical constraints; most clinical
laboratories do not routinely determine the species of the
organism or test the susceptibilities of anaerobic isolates
[15].
CIAO Study data indicate that 44.7% of patients were
tested for the presence of aerobic microorganisms.
The major pathogens involved in community-acquired
intra-abdominal infections are Enterobacteriaceae, Strepto-
coccus species, and certain anaerobes (particularly B. fragi-
lis). Compared to community-acquired infections,
healthcare-associated infections typically involved a
broader spectrum of microorganisms, encompassing
ESBL-producing Enterobacteriaceae, Enterococcus, Pseudo-
monas, and Candida species in addition to the Enterobac-
teriaceae, Streptococcus species, and anaerobes typically
observed in community-acquired IAIs.
The threat of antimicrobial resistance has become a
major challenge in the management of intra-abdominal
infections.
The main resistance threat is posed by ESBL-producing
Enterobacteriaceae, which are frequently found in
community-acquired infections.
According to the study’s preliminary findings, ESBL
producers were the most prevalent and commonly iden-
tified drug-resistant microorganism.
Two isolates of Klebsiella pneumoniae appeared to be
resistant to Carbapenems. These particular infections
were acquired in the intensive care unit.
The rate of Pseudomonas aeruginosa among aerobic
isolates was 4.6%. There was no statistically significant
difference in the Pseudomonas appearance rate between
community-acquired and healthcare-associated IAIs.
Enterococci (E. faecalis and E. faecium) were identified
in 14.5% of all aerobic isolates.
Although Enterococci were also present in community-
acquired infections, they were far more prevalent in
healthcare-associated infections.
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regarding the infectious trends of Candida species are
rather contradictory [16].
In the first half of the CIAO Study, 45 Candida iso-
lates (5.7%) were observed among a total of 825 isolates.
Candida prevalence was significantly higher in the
healthcare-associated IAI group than it was in the com-
munity-acquired IAI group.
Of the 912 patients enrolled in the study, there were
58 deaths (6.4%).
According to univariate statistical analysis of the data,
critical clinical condition of the patient upon hospital
admission (defined by severe sepsis and septic shock) as
well as healthcare-associated infections, non-appendicular
origin, generalized peritonitis, and serious comorbidities
such as malignancy and severe cardiovascular disease were
all significant risk factors for patient mortality. WBCs
greater than 12,000 or less than 4,000 and core body tem-
peratures greater than 38°C or less than 36°C by the third
post-operative day were statistically significant indicators
of patient mortality.
Conclusion
Complicated intra-abdominal infections remain an im-
portant cause of morbidity with poor clinical prognoses.
The purpose of the CIAO Study is to describe the epi-
demiological, clinical, microbiological, and treatment pro-
files of both community-acquired and healthcare-acquired
complicated intra-abdominal infections (IAIs) based on
the data collected over a six-month period (January 2012
to June 2012) from 66 medical institutions.
The final results of the CIAO Study will be published
following the conclusion of the study period in June 2012.
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